Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome

Q: Like COVID-19 virus, Decadron is recommended as treatment in patients with severe Middle East respiratory syndrome coronavirus (MERS-CoV).

A) True

B) False

Answer: B (False)

In patients with severe MERS-CoV glucocorticoid treatment showed no difference in mortality; instead, it was associated with a delay in clearance of the virus. It is not recommended in MERS-CoV infections.

#ID

Reference:

Arabi YM, Mandourah Y, Al-Hameed F, et al. Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome. Am J Respir Crit Care Med 2018; 197:757.